These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 7695889)
1. Pathoanatomical aspects of malignant haematological disorders among Danish patients exposed to thorium dioxide. Visfeldt J; Andersson M APMIS; 1995 Jan; 103(1):29-36. PubMed ID: 7695889 [TBL] [Abstract][Full Text] [Related]
2. Leukemia and other related hematological disorders among Danish patients exposed to Thorotrast. Andersson M; Carstensen B; Visfeldt J Radiat Res; 1993 May; 134(2):224-33. PubMed ID: 8488256 [TBL] [Abstract][Full Text] [Related]
3. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004]. Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876 [TBL] [Abstract][Full Text] [Related]
4. The incidence of secondary leukemias. Leone G; Mele L; Pulsoni A; Equitani F; Pagano L Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043 [TBL] [Abstract][Full Text] [Related]
5. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Preston DL; Kusumi S; Tomonaga M; Izumi S; Ron E; Kuramoto A; Kamada N; Dohy H; Matsuo T; Matsui T [corrected to Matsuo T] Radiat Res; 1994 Feb; 137(2 Suppl):S68-97. PubMed ID: 8127953 [TBL] [Abstract][Full Text] [Related]
6. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML. Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773 [TBL] [Abstract][Full Text] [Related]
7. Statistical analysis of Japanese Thorotrast-administered autopsy cases--1980. Mori T; Kato Y; Aoki N; Hatakeyama S Health Phys; 1983; 44 Suppl 1():281-92. PubMed ID: 6575000 [TBL] [Abstract][Full Text] [Related]
8. Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011. Morrison VA; Rai KR; Peterson BL; Kolitz JE; Elias L; Appelbaum FR; Hines JD; Shepherd L; Larson RA; Schiffer CA J Clin Oncol; 2002 Sep; 20(18):3878-84. PubMed ID: 12228208 [TBL] [Abstract][Full Text] [Related]
9. Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease. Tebbi CK; London WB; Friedman D; Villaluna D; De Alarcon PA; Constine LS; Mendenhall NP; Sposto R; Chauvenet A; Schwartz CL J Clin Oncol; 2007 Feb; 25(5):493-500. PubMed ID: 17290056 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathological study of hematological disorders after Thorotrast administration in Japan. Kamiyama R; Ishikawa Y; Hatakeyama S; Mori T; Sugiyama H Blut; 1988 Apr; 56(4):153-60. PubMed ID: 3162698 [TBL] [Abstract][Full Text] [Related]
11. Japanese patients with leukaemia following the use of Thorotrast including a patient with marked chromosomal rearrangements. Sadamori N; Miyajima J; Okajima S; Shima M; Yano M; Koga M; Kawamoto M; Fujii H; Mori T; Ichimaru M Acta Haematol; 1987; 77(1):11-4. PubMed ID: 3107315 [TBL] [Abstract][Full Text] [Related]
12. Geographical variation in the incidence of the leukemias and lymphomas. Weiss NS Natl Cancer Inst Monogr; 1979 Nov; (53):139-42. PubMed ID: 295090 [TBL] [Abstract][Full Text] [Related]
13. The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950-2001. Hsu WL; Preston DL; Soda M; Sugiyama H; Funamoto S; Kodama K; Kimura A; Kamada N; Dohy H; Tomonaga M; Iwanaga M; Miyazaki Y; Cullings HM; Suyama A; Ozasa K; Shore RE; Mabuchi K Radiat Res; 2013 Mar; 179(3):361-82. PubMed ID: 23398354 [TBL] [Abstract][Full Text] [Related]
14. Cancer incidence among Danish Thorotrast-exposed patients. Andersson M; Storm HH J Natl Cancer Inst; 1992 Sep; 84(17):1318-25. PubMed ID: 1495101 [TBL] [Abstract][Full Text] [Related]
15. Effects of preconceptional irradiation on mortality and cancer incidence in the offspring of patients given injections of Thorotrast. Andersson M; Juel K; Ishikawa Y; Storm HH J Natl Cancer Inst; 1994 Dec; 86(24):1866-7. PubMed ID: 7619110 [TBL] [Abstract][Full Text] [Related]
16. Age-related incidence and other epidemiological aspects of myelodysplastic syndromes. Aul C; Gattermann N; Schneider W Br J Haematol; 1992 Oct; 82(2):358-67. PubMed ID: 1419819 [TBL] [Abstract][Full Text] [Related]
17. Cancer in relatives of children with myelodysplastic syndrome, acute and chronic myeloid leukaemia. Hasle H; Olsen JH Br J Haematol; 1997 Apr; 97(1):127-31. PubMed ID: 9136952 [TBL] [Abstract][Full Text] [Related]
18. The german thorotrast study: recent results and assessment of risks. van Kaick G; Dalheimer A; Hornik S; Kaul A; Liebermann D; Lührs H; Spiethoff A; Wegener K; Wesch H Radiat Res; 1999 Dec; 152(6 Suppl):S64-71. PubMed ID: 10564940 [TBL] [Abstract][Full Text] [Related]
19. Mortality after radiological investigation with radioactive Thorotrast: a follow-up study of up to fifty years in Portugal. dos Santos Silva I; Malveiro F; Jones ME; Swerdlow AJ Radiat Res; 2003 Apr; 159(4):521-34. PubMed ID: 12643797 [TBL] [Abstract][Full Text] [Related]